GLP-1 Receptor Agonists and the Eye: Evidence, Mechanisms, and Clinical Guidance A new multidisciplinary expert consensus published in Diabetes, Obesity & Metabolism (2025) brings clarity to a question often raised in clinical practice: Do GLP-1 receptor agonists increase the risk of ocular complications such as diabetic retinopathy or optic neuropathy
So is the drug working on the digestive system specifically and only, or in terms of appetite control, is it also working on the brain
Recent studies have shown that muscle mass loss induced by GLP-1s can account for 1540% of total weight loss (7)
Check Blood Sugar When Appropriate People with diabetes, especially those using insulin or a sulfonylurea, should check glucose as directed when headache occurs with sweating, shaking, hunger, blurred vision, confusion, or weakness
Some observational studies have also examined the risk of incident T2DM in relation to changes in MASLD status over time